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ABSTRACT Cyanovirin-N (CVN) is a highly potent anti-HIV carbohydrate-binding agent that establishes its microbicide activity
through interaction with mannose-rich glycoprotein gp120 on the virion surface. The m4-CVN and P51G-m4-CVNmutants repre-
sent simple models for studying the high-afﬁnity binding site, BM. A recently determined 1.35 A˚ high-resolution structure of P51G-
m4-CVN provided details on the di-mannose binding mechanism, and suggested that the Arg-76 and Glu-41 residues are critical
components of high mannose speciﬁcity and afﬁnity. We performed molecular-dynamics simulations in solution and a crystal
environment to study the role of Arg-76. Network analysis and clustering were used to characterize the dynamics of Arg-76.
The results of our explicit solvent solution and crystal simulations showed a signiﬁcant correlation with conformations of
Arg-76 proposed from x-ray crystallographic studies. However, the crystal simulation showed that the crystal environment
strongly biases conformational sampling of the Arg-76 residue. The solution simulations demonstrated no conformational
preferences for Arg-76, which would support its critical role as the residue that locks the ligand in the bound state. Instead,
a comparative analysis of trajectories from >50 ns of simulation for two mutants revealed the existence of a very stable eight-
hydrogen-bond network between the di-mannose ligand and predominantly main-chain atoms. This network may play a key
role in the speciﬁc recognition and strong binding of mannose oligomers in CVN and its homologs.INTRODUCTION
Cyanovirin-N (CVN), a 101-residue-long lectin, belongs to
the group of carbohydrate-binding agents that establish their
antiviral activity through interaction with the carbohydrate
shields of viruses, including HIV, Ebola, and hepatitis C
(1–4). In the case of HIV, CVN binds to the mannose-rich
sugar moieties of the surface envelope glycoprotein gp120
and disrupts virion attachment to the host cell receptors
and virus-cell fusion mechanism (5–7). Additionally, CVN
has been reported to have potential for novel antiviral thera-
pies that result in the generation of virus modifications with
depleted glycan shields (such viruses are less protected
against immune response) (8). The origin of CVN’s high
specificity to mannose oligomers and details of the gp120
immobilization mechanism are still under intensive study
and discussion. A variety of experimental and computational
techniques have been used to address these questions,
including site mutations of the protein and ligand, structural
studies in solution and crystal, and molecular-dynamics
(MD) simulations (9–13). A summary of CVN structural
studies can be found in a recent review (14). An MD simu-
lation of CVN by Fujimoto et al. (15) focused on the docking
of tri-mannose to complement a corresponding experimental
study (12). The results of a previous MD simulation of native
CVN complexed with di-mannose (16) are of particular
interest here, as discussed further below.
The CVN mutants studied in this work were initially
created to determine the importance of multiple binding
modes for antiviral activity (17,18). Wild-type CVN exists
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and a unique domain-swapped dimer (70% and 25% at
pH < 5) (13). Although at neutral pH the monomeric form is
predominant in solution, only the crystal structures of the
domain-swapped dimer are known to contain native CVN
(14). Information on the CVN monomer geometry is based
on a CVN:dimannose structure from NMR solution experi-
ments (10). The monomer has two di-mannose specific
binding sites: AM and BM (M stands for monomeric). These
two binding sites are sequentially and structurally similar.
However, the AM binding site has a more shallow shape
that results in a lower affinity to di-mannose (Ka ~ 6.8 
105 M1) compared to the BM site (Ka ~ 7.2  106 M1),
which forms a deep pocket (10). Both of the mutants studied
in this work (m4-CVN and P51G-m4-CVN) have four muta-
tions (K3N, T7A, E23I, and N93A) that completely inacti-
vate the AM binding site, whereas P51G-m4-CVN has an
additional P51G mutation that stabilizes formation of the
monomer (Fig. 1 a). It appears that a multiple-site binding
mode is important for antiviral activity, although some ambi-
guity is present in the literature (17–19). Monomeric units of
the mutants under investigation still bind to gp120, but as
expected, and in contrast to both CVN and P51G-CVN,
they do not possess antiviral activity (20,21). Therefore,
the m4-CVN and P51G-m4-CVN monomeric units represent
simple models for studying binding-site BM.
The high specificity of CVN to mannose has been attrib-
uted in particular to hydrogen (H)-bonds between hydroxyl
groups of sugar ligand and protein side-chain atoms (10). In
the high-affinity binding site BM, H-bonding with the Glu-
41 residue side chain has been proposed as an important
component in the recognition and binding of the di-mannose
doi: 10.1016/j.bpj.2009.08.011
Solution and Crystal MD of CVN 2533FIGURE 1 (a) General view of the P51G-m4-CVN:di-
mannose complex. Four mutations (K3N, T7A, E23I, and
N93A), which completely inactivate the binding site AM
(the left half of the protein), and an additional P51G muta-
tion (binding-site BM, the right half of the protein), which
stabilizes the monomer, are shown as side chains. Side
chains of Glu-41 and Arg-76 are also shown. The di-
mannose hydrogens are removed for clarity. (b) H-bonding
of Arg-76 and Glu-41 with di-mannose residues in the
binding-site BM as possible factors of CVN specificity.
The picture presents one of the frames from the
m4-CVN:di-mannose complex solution simulation.
However, this configuration is very transient in our simula-
tion. (c) A network created from the 500-frame sampling
set (points) and six representative structures from clus-
tering based on 5000 frames (numbered white circles).
The graph is based on the RMSD pairwise matrix calcu-
lated for the structure fragment that includes nonhydrogen
atoms of the Arg-76 residue and the closest residue of
di-mannose. Links between nodes are attributed to <0.75 A˚
RMSD between the fragments of corresponding structures.
The representative structures identify the most populated
clusters. The size of the node is proportional to the cluster
population. The most and least populated clusters, clusters
1 and 6, include 1665 and 101 frames, respectively. The
first three and all six clusters respectively cover 84% and
97% of conformational space observed in the last 50 ns
of simulation of the P51G-m4-CVN:di-mannose complex
in solution. (d) A network created from the 950-frame
sampling set from the P51G-m4-CVN:di-mannose com-
plex simulations in solution and crystal. Nodes are coded
as follows: (small circles) 500 frames from 50 ns solution
simulations; (triangles and diamonds) 30 ns crystal simula-
tions of chain a (150 frames) and chain b (300 frames),
respectively; (labeled squares) experimentally observed
conformations of chain a, and two alternative conformations of chain b. White circles depict the positions of the representative structures for the most populated
clusters in the solution simulation. Nodes between major clusters correspond to transient conformations, whereas the peripheral nodes belong to the very low
populated clusters.ligand (16,22) (Fig. 1, a and b). Another interesting feature
of the binding-site BM is the presence of the Arg-76 residue.
An earlier MD simulation of a native CVN:di-mannose
complex indicated that two side-chain nitrogen atoms of
Arg-76 form H-bonds with two oxygen atoms of di-
mannose (Fig. 1 b) and lock the ligand in the binding
pocket (16). Arg-76 remained in that locking conformation
for more than half of the entire 20 ns simulation, in contrast
to the generally very high mobility of the arginine residue.
A very similar ‘‘capping’’ conformation was observed in
an NMR structural study (10). In a recent x-ray diffraction
investigation of the P51G-m4-CVN:di-mannose complex,
two independent polypeptide chains (‘‘a’’ and ‘‘b’’) were
found in the asymmetric unit. Although the two chains
have nearly identical conformations, in one of them the ro-
tameric state of the Arg-76 residue is somewhat similar to
previously observed ligand gating configurations (22). In
the a chain, Arg-76 has one conformation and the ligand
is exposed to surrounding media. In the b chain, it is disor-
dered on two alternative positions with 80:20% occupancy,
and in both conformations it partially ‘‘covers’’ the ligand inthe binding site (22). This result was interpreted as experi-
mental support for the previously proposed capping-and-
locking function of the Arg-76 residue. However, one
should be careful to avoid overinterpreting a crystal struc-
ture.
Crystal structures represent a confined medium that may
introduce biophysical and biochemical artifacts due to inter-
actions of a protein complex with neighboring molecules
(23,24). In this work, we reconsider the critical importance
of Arg-76 for CVN specificity to di-mannose based on the
results of explicit solvent MD simulations of the P51G-
m4-CVN:di-mannose complex in solution and in the crystal
environment to examine whether the conformations of Arg
76 from x-ray data accurately represent the conformations
in solution. We also used solution MD simulations of the
P51G-m4-CVN:di-mannose and m4-CVN:di-mannose com-
plexes to study the dynamics of the entire protein-ligand
H-bond network. It appears that the interaction of hydroxyl
groups of the di-mannose ligand with predominantly main-
chain atoms is one of the major ligand-protein complex stabi-
lizing factors in the binding site BM.Biophysical Journal 97(9) 2532–2540
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tively rare and more methodologically challenging than
MD simulations in solution (25). Applications of MD crystal
simulations include studies of solute and solvent transport in
protein crystals (26,27), simulations of protein dynamics in
the crystal (28,29), testing of force fields (30–32), and explo-
rations of the crystal packing influence on protein structure
and dynamics. Our study falls in the last category. In a
recent work on Neuroglobin (Ngb) Anselmi et al. (23)
demonstrated that significant structural changes in ferrous
CO-bound Ngb are caused by the crystal environment rather
than peculiarities of the heme-binding mechanisms. In
another investigation, Neugebauer et al. (24) showed that
conformations of two important helical binding regions in
the crystal structure of the human CD81 receptor are affected
by crystal contacts, and the observed structure does not
represent the native state of the protein. In this study, we
focus on comparing the conformational sampling of a partic-
ular binding-site residue, Arg-76, in the crystal environment
and in solution, and on how it relates to the mechanism of the
CVN interaction with oligomannose. To describe the Arg-76
conformational sampling, we used well-established clus-
tering techniques (33) as well as network analysis (34).
Network analysis allows visualization of results of the
‘‘classical’’ clustering algorithms and conformational space
sampling from different simulations on one plot, which can
be very useful for comparative analyses and for under-
standing topological relationships between clusters.
MATERIALS AND METHODS
General
The details of the MD simulations are summarized in Table S1 of the Sup-
porting Material. The initial coordinates of the P51G-m4-CVN:di-mannose
complex were taken from a 1.35 A˚ resolution crystal structure of this
complex (Protein Data Bank (PDB) ID: 2RDK) (22). Residues 2–101, all
of which are visible on the electron density map, were included in modeling,
as was a his-tag linkage residue, Leu-102, which is also ‘‘visible’’ in the
crystal structure. Both the C- and N-termini are far from the binding site
BM. The model for m4-CVN:di-mannose was constructed with the assis-
tance of the native CVN:di-mannose structure determined by solution
NMR (PDB ID: 1IIY) (10). The di-mannose ligand used in the simulations
was the Mana(1/2)Mana oligomer. All simulations were performed using
the Amber 10 package (35,36). Residues were protonated to correspond to
the neutral pH. The only histidine residue in the system was uncharged
(proton on N3), all five aspartic and five glutamic acid residues were nega-
tively charged, and all three arginine and four lysine residues were positively
charged. The histidine residue is far from the ligand-binding site, and its
protonation state should not affect our results. A total negative charge of
3e on the protein was neutralized by the addition of three Naþ counterions.
Input coordinates, topology, and force-field parameters files were created
with the tleap program (37).
Amber FF03 and GLYCAM06 force-field parameters were used for the
proteins and ligand, respectively (38–41). A discussion about the choice
of force field is presented in the Supporting Material. Nonbonded and elec-
trostatic energy scaling factors were set according to the FF03 parameteriza-
tion: SCNB ¼ 2.0 and SCEE ¼ 1.2. Deviation of these scaling factors from
unity, with which GLYCAM06 was parameterized, may degrade the accu-
racy of the rotamer sampling of carbohydrates; however, since di-mannoseBiophysical Journal 97(9) 2532–2540stays bound in one conformation, this should not affect our results. For simu-
lations in both NVT and NPT ensembles, the temperature was maintained by
Langevin dynamics with a collision frequency of 1 ps1. The random
number generator was reseeded at every simulation restart (every 200 ps)
(42). A cutoff of 10 A˚ and the particle mesh Ewald method for simulation
of periodic boundaries were used to calculate long-range nonbonded interac-
tions (default parameters include grid spacing of 1.0 A˚ combined with
fourth-order B-spline interpolation). Constant-pressure simulations were
performed at an average pressure of 1 atm, employing an isotropic position
scaling algorithm and a relaxation time of 2 ps. All simulations were done
with explicit TIP3P water. SHAKE constraints with the tolerance parameter
of 105 A˚ were applied to eliminate bond-stretching freedom for all bonds
involving hydrogen. The simulation jobs were run in parallel using 8 and 16
processor clusters at the University of Arizona High Performance
Computing Center. All trajectories were processed with ptraj and visualized
with VMD (33,43). Graphical presentations were prepared using Pymol and
LigPlot (44,45).
Solution simulations
For the MD simulations, a neutralized P51G-m4-CVN:di-mannose complex
was solvated with 10,722 water molecules using a truncated octahedron
box with a buffer distance of 14 A˚ in all three directions. The initial energy
minimization was performed in two steps. The first step included 500 steep-
est descent minimization cycles followed by 500 conjugate gradient minimi-
zation cycles. Coordinates of the protein complex were ‘‘fixed’’ at the start-
ing positions using harmonic restraints with a force constant of 500 kcal/
(mol $ A˚2), whereas solvent molecules (water and Naþ) were allowed to
relax the unfavorable contacts between each other and with the solute.
The second step consisted of 1000 steepest descent and 1500 conjugate
gradient cycles of energy minimization for the entire system with no posi-
tional restraints. Next, the system was heated up from 0 to 300 K during a
20 ps MD simulation run with a 0.002 ps time step and weak positional
restraints on the solute (force constant of 10 kcal/(mol $ A˚2)). Finally, a
52 ns production run in the NVP ensemble was performed with a time
step of 0.002 ps; the first 200 ps of the run included equilibration. There
were no harmonic restraints on the system. Output coordinate files were
written every 0.5 ps. The same protocol was used for all solution simula-
tions. These conditions produced stable trajectories as structures of the
protein and ligand were maintained throughout the simulations, as evidenced
by comparing the root mean-square displacement (RMSD) against the start-
ing minimized complexes (see Fig. S1).
Crystal simulations
The P51G-m4-CVN:di-mannose complex was crystallized in the monoclinic
unit cell with the space group P21 and parameters a ¼ 49.205, b ¼ 38.452,
c ¼ 55.953 A˚, and b ¼ 99.94 (PDB ID: 2RDK). A corresponding triclinic
unit cell contained four protein-ligand pairs. To solvate the system, a 3 
3  3 crystal block was constructed from 27 triclinic unit cells. This crystal
block was ‘‘submerged’’ into a rectangular solvation box with a buffer
distance of 6 A˚ around the solute. The box was filled with 135,897 water
molecules to a final density of 1 g/cm3 for the entire system. The energy
of the 27-unit cell solvated system was minimized in two steps. First, the
solvent was relaxed though 2000 steepest descent and 2000 conjugate
gradient energy minimization cycles. Coordinates of solute atoms were
restrained to their initial values with a force constant of 500 kcal/(mol $ A˚2).
Next, the energy of the solvent, ligands, and protein side chains was mini-
mized in 3000 steepest descent and 4000 conjugate gradient cycles, whereas
the main-chain atoms of the solute remained restrained with the same force
constant. After minimization, the system was heated up to 300 K during a
20 ps simulation followed by a 40 ps equilibration run in the NVT ensemble
with the same positional restraints to main-chain atoms. This preliminary
simulation was performed to allow water molecules to evenly fill up the
space between protein molecules.
Solution and Crystal MD of CVN 2535For the crystal simulations, the central unit cell was ‘‘cut out’’ from the
27-unit cell block. This system included four protein chains with ligands,
12 Naþ counterions, and 1557 water molecules. Periodic boundary param-
eters were set to be equal to the parameters of the triclinic unit cell. The
density of the system was equal to 1.16 g/cm3. An evaluation of our solva-
tion model is presented in detail in the Supporting Material. The energy of
the system was again minimized in 2000/2000 steepest descent/conjugate
gradient cycles to relax water molecules, followed by 3000/4000 steepest
descent/conjugate gradient cycles to relax unfavorable contacts between
solvent molecules and side chains of the solute. Then the system was heated
up to 300 K during a 20 ps run with positional harmonic restraints on the
main-chain atoms (force constant of 500 kcal/(mol $ A2)). A 16 ns produc-
tion run in the NVT ensemble was performed with no positional restraints.
Output coordinate files were produced every 1 ps of simulation. The initial
crystal arrangement was preserved throughout the simulations, as evidenced
by comparing the RMSD against the starting model derived from the exper-
iment (Fig. S2).
Clustering and network representation
Network representations and clustering were used for analyses of the confor-
mational ensembles of Arg-76 (33,34). Clustering and network construction
were both based on the RMSD pairwise matrix. Nonhydrogen atoms for the
Arg-76 residue and a di-mannose residue adjacent to Arg-76 were included
in RMSD calculations. For the network representation, we employed a
force-directed layout algorithm that is a part of the Cytoscape program
(46). In brief, the network is a graph consisting of nodes that represent
sampled configurations of the system, and links (edges) that represent simi-
larity between configurations. The links are established by a cutoff applied to
the RMSD matrix. Results from a series of trials indicated that an RMSD
cutoff of 0.75 A˚ distinguished well between different clusters. Upon
construction of the force-directed layout, the potential energy of the graph
undergoes minimization as a virtual physical system in which links are
modeled as springs (attractive forces) and all nodes have an electrical repul-
sion between them. For clustering, we utilized the average linkage algorithm
implemented in ptraj. The uniqueness or equivalence of different clusters
was assessed based on visual comparison of representative structures.
More details on the use of clustering and network analysis are presented
in the Supporting Material.
The most effective way to use unweighted force-directed network
constructions is to 1), reveal clusters and their content; and 2), establish
connections between clusters. A network representation of ensemble config-
urations is helpful for visualizing the topology of the conformational space
in a way that cannot be easily done with clustering analysis (especially for
a flexible residue such as arginine, which has >30 rotameric states (47)).
However, network processing is memory-demanding and limits the number
of nodes that can be computationally handled and represented in a visually
informative way to ~1000. In our case, to represent a 50 ns trajectory, we had
to sample ~500 configurations, corresponding to the wide sampling rate of
100 ps. Nevertheless, in our preliminary investigation (see the Supporting
Material) we found that the 500-frame sampling set reasonably covered
the most populated part of the conformational space of the Arg-76 residue
in solution (Fig. 1 c). The clustering was performed on a 5000-frame refer-
ence set (10 ps sampling rate).
RESULTS
Comparison of Arg-76 conformational sampling
in solution and crystal
Fig. 1 c shows the assignment of a network constructed from
500 Arg-76 conformations from the solution simulation to
the six most-populated clusters from the 5000-frame refer-
ence sampling set. This figure primarily demonstrates thehigh mobility of the Arg-76 residue in the ‘‘free’’ protein
complex, and the existence of three major preferable config-
urations and two minor ones. The highest-rank clusters (clus-
ters 1–3) from the MD simulation correspond to Arg-76
conformations identified by x-ray crystallography, as is
evident from Fig. 1 d. This remarkable agreement indicates
the quality of the structural information from the x-ray
data, as well as the reliability of the model from the MD
simulation.
Further analysis illuminates the effects of crystal packing
on the Arg-76 conformational ensemble. Fig. 1 d represents a
network consisting of 950 frames from the P51G-m4-
CVN:di-mannose complex simulations in both solution and
crystal. These 950 nodes include 500 frames from the solu-
tion simulation and 150þ300 frames from the crystal simu-
lation of chains a and b. As can be seen from the figure, the
a chain includes only one conformation for the Arg-76
residue, which corresponds to cluster 3 from the solution
simulation (Fig. 1 c). Analysis of the crystal packing indi-
cates that Arg-76 of the a chain is trapped in this experimen-
tally observed conformation because of direct interactions
with a neighboring molecule (Fig. S4). In contrast, in the
b chain the Arg-76 residue is exposed to solvent, and sam-
ples almost the same conformational space as in solution
(Table S2). Nonetheless, in agreement with our calculations,
two conformations observed experimentally in the crystal
(b1 and b2) correspond to the two most occupied clusters
(clusters 1 and 2), and the b1 conformation is more populated
than b2 (Table S2). Yet, the simulation indicates that the
Arg-76 residue in the b chain is disordered at room temper-
ature at least by five positions, and the precision of the exper-
iment does not allow resolution of all these conformations.
MD simulation also complements the experiment with
more details about the nature of the Arg-76 disorder in the
b chain, providing information on the timescale of Arg-76
dynamics. Arg-76 remained in one conformation for less
than ~2.3 ns and changed its conformation numerous times
during the 50 ns simulation. We note that the B-factor of
the residue is not very high, but that does not contradict
our observation. A detailed analysis of disordered fragments
is beyond the capabilities of a single-temperature routine
x-ray diffraction experiment because of strong correlations
between positional, thermal, and occupational parameters
(48). However, the fact that this residue is disordered indi-
cates that it is flexible.
The MD simulations show that the conformation observed
in the a chain is trapped and probably should not be treated
as experimental evidence of Arg-76 participation in the
binding-site gating mechanism. Additionally, the ‘‘trapped’’
Arg-76 conformation in the a chain appears to be shifted off
of the centroid of cluster 3 from the solution simulation. The
presence of this extra packing effect can hardly be noted on
Fig. 1 d because of limitations of the network presentation
(see the Supporting Material for details). To elucidate the
effect, we calculated distributions of Arg-76 RMSDs fromBiophysical Journal 97(9) 2532–2540
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0–0.75 A˚ on the histograms corresponds to cluster 1 or
cluster 3 from the solution simulation of the P51G-m4-
CVN:di-mannose complex (Fig. 1, c and d). As can be
seen from the upper histogram, the experimentally observed
conformation ‘‘a’’ lies on the slope of the distribution. Thus,
this configuration is shifted from the cluster 3 centroid,
which corresponds to the closest rotameric state. In contrast,
the experimentally observed configurations b1 and b2 (not
shown) appear to be very close to centroids of clusters 1
and 2, since the RMSD distributions have maxima in the
range of 0–0.75 A˚ (Fig. 2). These results are in line with
the fact that Arg-76 in the b chain does not have direct inter-
actions with neighboring proteins that could otherwise affect
FIGURE 2 Distributions of Arg-76 RMSD in solution against experimen-
tally observed conformations in chains a and b. The upper and bottom panels
demonstrate two situations in which the experimentally observed conforma-
tions stay, respectively, off of and close to centroids of the corresponding
clusters. ‘‘Cutoff’’ denotes the 0.75 A˚ cutoff applied to assign links between
nodes (configurations) for force-directed network constructions (Fig. 1, c
and d).Biophysical Journal 97(9) 2532–2540the position and conformational sampling of this residue. In
conclusion, the crystal environment of the P51G-m4-CVN:
di-mannose complex not only traps Arg-76 of the a chain
in a single conformation, it also distorts it from its closest
rotamer geometry.
Conformational sampling of Arg-76 from
P51G-m4-CVN and m4-CVN solution simulations
Fig. 3 represents conformations of the Arg-76 residue from
representative structures for the six most-populated clusters
observed in the last 50 ns of simulation of the P51G-m4-
CVN:di-mannose complex in solution. The first five clusters
are mt(t/m/p)X rotamers, according to the nomenclature of
Penultimate Rotamer Library, i.e., they are related to each
other through rotation around Cg-Cd and Cd-N3 bonds (47).
Cluster 6 is close to ttm85 rotamer. All of these conforma-
tions, except for cluster 5, are in the top list of the most
frequently observed arginine conformations. These results
demonstrate no pronounced preference for Arg-76 to adopt
conformations specific for gating-and-locking of di-mannose
in the binding site, and bring into question the relevance of
this mechanism for high oligomannose specificity. Addition-
ally, we did not observe the statistically most favorable
mtt180 conformation (according to the Penultimate Rotamer
Library) as a stable one, in contradiction to the previous
conclusion from MD simulations of native CVN (16). Also,
formation of the double H-bond between the guanidinium
fragment of Arg-76 and two oxygens of di-mannose, related
to this mtt180 configuration (Fig. 1 b), took place only
occasionally and at best for only a few consecutive frames
(for ~1–2 ps). This result was quite unexpected, so we decided
to investigate whether a P51G mutation could cause such
a difference in Arg-76 conformational sampling.
FIGURE 3 Conformations of the Arg-76 residue from representative
structures for the six most populated clusters from the last 50 ns of simula-
tion of the P51G-m4-CVN:di-mannose complex in solution (sampling rate:
10 ps). The closest rotamers are mtt85 for cluster 1, mttþ85 for cluster 2,
mtm180 for cluster 3, mtp105 for cluster 4, mtp180 for cluster 5, and
ttm85 for cluster 6, according to the nomenclature adopted in the Penul-
timate Rotamer Library (47). In the rotameric state notation, t, m, and p are
used to describe the sequence of trans-, minus, and plus gauche-conforma-
tions, respectively, in the aliphatic part of arginine, and the last number
describes the orientation of the guanidinium fragment.
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m4-CVN:di-mannose complex that did not have a G51P
mutation and therefore had the same binding site as native
CVN. We found that Arg-76 samples the same conforma-
tional space as in the P51G-m4-CVN:di-mannose complex
(Fig. S5 and Table S2). Once again, during a 52 ns simula-
tion of m4-CVN:di-mannose, we did not observe formation
of the double H-bond between Arg-76 and di-mannose as a
stable configuration. Moreover, in the control 16 ns solu-
tion simulation of native CVN, we encountered no such
configuration at all. The last simulation was performed on
exactly the same system as in previous work, and could
be expected to reproduce the published results. The origin
of this contradiction remains undetermined. At another
extreme, Fujimoto et al. (15) mentioned that in their simula-
tions of CVN, the Arg-76 residue did not make any specific
interactions with the sugar. Such variations in computational
results may be caused by the use of different force fields and
have to be resolved by experiment. Considering the remark-
able agreement between the conformations observed in our
MD simulation and x-ray structure, we believe our MD
protocol is sufficiently reliable. In any case, our results
oppose the suggestion of a special role for Arg-76 in
di-mannose binding by CVN.
DISCUSSION
Importance of Arg-76
The results of the P51G-m4-CVN:di-mannose complex
simulation in solution and crystal, as well as m4-CVN:di-
mannose simulation in solution, bring into question the
importance of Arg-76 as the residue that locks the ligand
in the bound state (the lid). They demonstrated no conforma-
tional preferences for Arg-76 toward tight interaction with
the di-mannose ligand. Thus, other factors that could provide
high specificity of CVN for oligo-mannose should be
analyzed. To address this issue, we compared BM binding
sites in P51G-m4-CVN, m4-CVN and homologs from the
CVN Homology (CVNH) family (49,50).
Sequence alignment of homologs from the CVNH family
was previously performed by Percudani et al. (49). Experi-
mental solution structures of three of these homologs were
also recently established (50). For the purpose of our study,
two important observations can be derived from the sequen-
tial comparative analysis. First, Arg-76 is not a well-
conserved residue. The conservation rate is only 31% among
16 homologs. The majority of homologs (56%) contain small
and/or hydrophobic residues (Gly, Ala, Val, Ser, Thr, Cys,
and Pro), which are not the functional analogs of the
Arg-76 residue. In line with our previous conclusion, this
observation again casts doubt on the importance of Arg-76
for CVN specificity. Second, the majority (75%) of CVN
homologs have a ‘‘P51G’’ mutation in the binding-site BM.
Thus, the P51G-m4-CVN mutant appears to be more repre-sentative of the BM binding site in the CVNH protein family
than m4-CVN. To obtain more details about the possible
influence of the P51G alteration on the structure of the
binding site, we decided to compare the structures of three
known homologs and two CVN mutants (P51G-m4-CVN
and m4-CVN).
Fig. S6 presents a superposition of five structures: P51G-
m4-CVN:di-mannose and m4-CVN:di-mannose complexes,
and experimentally determined solution structures of
Cr_CVN (after Ceratopteris richardii, PDB ID: 2JZJ),
Tb_CVN (Tuber borchii, PDB ID: 2JZK) and Nc_CVN
(Neurospora crassa, PDB ID: 2JZL). The structures of the
CVN mutants correspond to their energetically minimized
geometries, but are very close to the experimental structures
used as initial models for the simulations. The RMSD for all
nonhydrogen atoms of the original PDB coordinates of the
P51G-m4-CVN:di-mannose complex (PDB ID: 2RDK) and
the minimized structure is 0.486 A˚. The analogous value for
m4-CVN:di-mannose structures is 0.566 A˚ (the initial model
was created from PDB IDs 1IIY and 2RDK; see Materials and
Methods). Experimental structures for CVN homologs are in
apo forms and thus do not have any ligand. Because of this
feature, one can note pronounced flexibility of the 74–79
loop, which contains the Arg-76 residue in CVN (Fig. S6).
Based on this observation, we speculate that the whole loop
(rather than one residue) may participate in accommodation
of the ligand in the binding-site BM.
Our conclusion that the Arg-76 residue does not appear to
be critically important for keeping di-mannose in the bound
state probably should be considered as a hypothesis to be
tested experimentally. Indirect experimental support for
this conclusion comes from the fact that at least two CVN
homologs, Cr_CVN and Nc_CVN (which have Ala and
Cys, respectively, in place of Arg-76), bind to di-mannose,
as evidenced by 1H-15N heteronuclear single quantum coher-
ence NMR spectroscopic experiments (9). Also, it has been
shown that one of the CVN mutants, CV-NmutDB, which has
four mutations in the binding site BM (E41A, N42A, T57A,
and R76A), does not bind mannose oligomers (11). This
result does not contradict our conclusion, since the Thr-57
residue (but not Glu-41 and Arg-76) seems to be very impor-
tant for binding of di-mannose, as discussed below. Finally,
in our trial 16 ns MD simulation of the m4-CVN:di-mannose
complex with Glu-41 and Arg-76 ‘‘mutated’’ to Ala, the
ligand remained in the bound state for the entire run. It is still
possible that polar residues such as Glu-41 and Arg-76 may
play a role in the initial attraction and orientation of
di-mannose before binding, but that process is beyond the
scope of our study.
Another interesting finding from the structural alignment
of CVNH family members is that the 49–52 loop also adopts
several different conformations (Fig. S6). We investigated
the effect of the P51G mutation to the binding site BM and
made the following observations (see the Supporting Mate-
rial for details): 1), P51G-m4-CVN and m4-CVN representBiophysical Journal 97(9) 2532–2540
2538 Vorontsov and Miyashitatwo distinctive and stable main-chain pathways for loop
49–52 among structurally characterized members of the
CVNH family (Fig. S7); 2), in the m4-CVN:di-mannose
complex, Ser-52 is directed toward the di-mannose ligand,
causing a 0.86 A˚ ligand shift with respect to its position in
P51G-m4-CVN:di-mannose; and 3) despite that, the ligands
remained in the bound state for the entire duration (>50 ns)
of the simulations (Fig. S1). In our further search for an
explanation for the stability of these protein-ligand com-
plexes, we decided to analyze the entire H-bonding network
as a factor that could provide strong and stable attractive
interactions between the protein and ligand.
H-bond network of the ligand-binding site BM
Di-mannose ligand forms an extended H-bond network with
the protein. Based on the global analysis of all direct interac-
tions between two mutants and the ligand, we found that
discussion of this network could be reduced to eight essential
H-bonds. By ‘‘essential’’, we mean that a particular H-bond
is present most of the time (>74%) during the simulation. It
is interesting that all eight essential components of this
network are the same in both P51G-m4-CVN and
m4-CVN (Fig. 4). Three out of four di-mannose oxygen atoms
simultaneously play the roles of donor and acceptor of
H-bonds, and the average time during which the ligand is
involved in this H-bonding is 94% and 97% for P51G-m4-
CVN and m4-CVN, respectively (Fig. S8). The di-mannose
ligand donates H-bonds to the main-chain oxygen atoms of
the Asn-42, Lys-74 (or Val-43), Asn-53, and Ser-52 residues
while accepting H-bonds from main-chain nitrogen atoms of
residues Asn-42 and Asp-44, and side-chain Og of Thr-57.
This H-bond net occasionally expands by direct H-bonds
with side chains of residues Glu-56, Glu-41, Thr-75, Arg-76,
and Gln-78. Concerning Glu-41, it is interesting that all other
members of the CVNH family have absolutely conserved
Gly instead of the Glu residue. Additionally, an O-H.O
H-bond with O3 of Glu-41, and an N-H.O H-bond with
the terminal amino group of Arg-76 occur only 9% and
6% of the time, respectively. This again brings into question
the critical importance of these residues for CVN specificity
to di-mannose (Fig. S8). In contrast, based on the multiple
character and stability of the ‘‘essential’’ H-bond pattern in
our simulations, we suggest that these interactions are a
major factor in the specificity and high affinity of CVN
toward mannose oligomers.
Our simulations provide a fully atomistic picture of
H-bonding between CVN and di-mannose in the binding
site BM. This picture is in agreement with Sandstrom et al.’s
(9) conclusion that 30- and 40-hydroxyl groups play a key
role in high-affinity binding, based on the results of their
NMR study of CVN interactions with di-mannose deoxy
analogs. Regarding our set of eight ‘‘essential’’ H-bonds,
only the interaction with Og of Thr-57 was mentioned as
a potential H-bond in the first CVN:di-mannose solutionBiophysical Journal 97(9) 2532–2540structure (10). The presence of the ‘‘essential’’ H-bonds could
be deduced from the crystal structures of the P51G-m4-
CVN:di-mannose complex, but none were discussed in any
detail (18,22). The H-bonding descriptions in these structural
investigations were at best limited to interactions with amino
residue side chains. To our knowledge, our study provides the
first full description of direct H-bonding with di-mannose in
the binding-site BM. In particular, the MD simulations indi-
cate that almost all of the interactions with side chains were
very transient. On the other hand, taking into account that
seven out of eight ‘‘essential’’ interactions occurred with
main-chain atoms, and the remaining one interaction occurred
with a conserved Thr/Ser-57 residue, we could extrapolate
that these H-bonds would also play a key role in the oligoman-
nose specificity in other members of the CVNH family.
CONCLUSIONS
We performed MD simulations of a cyanovirin P51G-m4-
CVN mutant to investigate the conformational flexibility of
Arg-76, which has been considered to be important for
ligand binding. The results from the MD simulations
revealed a high flexibility of Arg-76 and identified its three
stable conformers, which are in remarkable agreement with
a recent high-resolution x-ray structure. However, a compar-
ison of the MD simulations in solution and in the crystal
environment indicates that one of the three conformers
observed in the x-ray structure is influenced by crystal
FIGURE 4 ‘‘Essential’’ H-bond network in the P51G-m4-CVN:
di-mannose complex as revealed by the explicit water simulation. Three
out of four di-mannose oxygen atoms simultaneously play the roles of donor
and acceptor of H-bonds; the average time during which the ligand is
involved in this H-bonding is 94% and 97% for P51G-m4-CVN and
m4-CVN, respectively. Hydrogen atoms are removed for clarity.
Solution and Crystal MD of CVN 2539packing. For the second symmetrically independent poly-
peptide chain, the MD simulation complements the experi-
ment and provides more details about the dynamic nature
of Arg-76.
The combination of network analysis and the clustering
method proved to be useful for analyzing conformational
ensembles. Network representation can visualize relation-
ships between clusters, and differences in conformational
ensemble in solution and crystal were clearly illustrated as
changes in the topology of the network.
Our results bring into question the importance of the Glu-
41 and Arg-76 residues for cyanovirin’s high specificity to
di-mannose. Both residues participated in H-bonding with
di-mannose for only a small fraction of time during the simu-
lations. In addition, these residues are not conserved among
homologs. Analysis of specific protein-ligand interactions
revealed a strong and stable H-bond network between O3
and O4 hydroxyl groups of mannose residues and predomi-
nantly main-chain oxygen and nitrogen atoms. The finding
that these eight essential H-bonds may play a key role in
the high specificity of cyanovirin to oligomannose is in
agreement with recent experimental evidence. However,
our conclusion that the conformations of Glu-41 and Arg-76
likely do not relate to binding stability needs to be evaluated
experimentally.
SUPPORTING MATERIAL
Two tables and 12 figures are available at http://www.biophysj.org/biophysj/
supplemental/S0006-3495(09)01367-8.
We thank Dr. R. Fromme and Dr. G. Ghirlanda for providing us with struc-
tural data and for helpful discussions. Calculations were performed at the
University of Arizona High Performance Computing Center.
This study was supported by the University of Arizona startup fund.
REFERENCES
1. Boyd, M. R., K. R. Gustafson, J. B. McMahon, R. H. Shoemaker, B. R.
O’Keefe, et al. 1997. Discovery of cyanovirin-N, a novel human immu-
nodeficiency virus-inactivating protein that binds viral surface envelope
glycoprotein gp120: potential applications to microbicide development.
Antimicrob. Agents Chemother. 41:1521–1530.
2. Barrientos, L. G., B. R. O’Keefe, M. Bray, A. Sanchez, A. M. Gronenborn,
et al. 2003. Cyanovirin-N binds to the viral surface glycoprotein, GP1,2
and inhibits infectivity of Ebola virus. Antiviral Res. 58:47–56.
3. Barrientos, L. G., F. Lasala, J. R. Otero, A. Sanchez, and R. Delgado.
2004. In vitro evaluation of cyanovirin-N antiviral activity, by use of
lentiviral vectors pseudotyped with filovirus envelope glycoproteins.
J. Infect. Dis. 189:1440–1443.
4. Helle, F., C. Wychowski, N. Vu-Dac, K. R. Gustafson, C. Voisset, et al.
2006. Cyanovirin-N inhibits hepatitis C virus entry by binding to enve-
lope protein glycans. J. Biol. Chem. 281:25177–25183.
5. Shan, M., P. J. Klasse, K. Banerjee, A. K. Dey, S. P. Iyer, et al. 2007.
HIV-1 gp120 mannoses induce immunosuppressive responses from
dendritic cells. PLoS Pathog. 3:e169.
6. Tsai, C. C., P. Emau, Y. Jiang, M. B. Agy, R. J. Shattock, et al. 2004.
Cyanovirin-N inhibits AIDS virus infections in vaginal transmission
models. AIDS Res. Hum. Retroviruses. 20:11–18.7. Tsai, C. C., P. Emau, Y. Jiang, B. Tian, W. R. Morton, et al. 2003.
Cyanovirin-N gel as a topical microbicide prevents rectal transmission
of SHIV89.6P in macaques. AIDS Res. Hum. Retroviruses. 19:535–541.
8. Hu, Q., N. Mahmood, and R. J. Shattock. 2007. High-mannose-specific
deglycosylation of HIV-1 gp120 induced by resistance to cyanovirin-N
and the impact on antibody neutralization. Virology. 368:145–154.
9. Sandstrom, C., B. Hakkarainen, E. Matei, A. Glinchert, M. Lahmann,
S. Oscarson, L. Kenne, and A. M. Gronenborn. 2008. Atomic mapping
of the sugar interactions in one-site and two-site mutants of cyanovirin-
N by NMR spectroscopy. Biochemistry. 47:3625–3635.
10. Bewley, C. A. 2001. Solution structure of a cyanovirin-N:Man
a1–2Mana complex: structural basis for high-affinity carbohydrate-
mediated binding to gp120. Structure. 9:931–940.
11. Barrientos, L. G., E. Matei, F. Lasala, R. Delgado, and A. M. Gronenborn.
2006. Dissecting carbohydrate-Cyanovirin-N binding by structure-
guided mutagenesis: functional implications for viral entry inhibition.
Protein Eng. Des. Sel. 19:525–535.
12. Botos, I., B. R. O’Keefe, S. R. Shenoy, L. K. Cartner, D. M. Ratner,
et al. 2002. Structures of the complexes of a potent anti-HIV protein cy-
anovirin-N and high mannose oligosaccharides. J. Biol. Chem.
277:34336–34342.
13. Botos, I., T. Mori, L. K. Cartner, M. R. Boyd, and A. Wlodawer. 2002.
Domain-swapped structure of a mutant of cyanovirin-N. Biochem.
Biophys. Res. Commun. 294:184–190.
14. Ziolkowska, N. E., and A. Wlodawer. 2006. Structural studies of algal
lectins with anti-HIV activity. Acta Biochim. Pol. 53:617–626.
15. Fujimoto, Y. K., R. N. Terbush, V. Patsalo, and D. F. Green. 2008.
Computational models explain the oligosaccharide specificity of cyano-
virin-N. Protein Sci. 17:2008–2014.
16. Margulis, C. J. 2005. Computational study of the dynamics of mannose
disaccharides free in solution and bound to the potent anti-HIV virucidal
protein cyanovirin. J. Phys. Chem. B. 109:3639–3647.
17. Chang, L. C., and C. A. Bewley. 2002. Potent inhibition of HIV-1
fusion by cyanovirin-N requires only a single high affinity carbohydrate
binding site: characterization of low affinity carbohydrate binding site
knockout mutants. J. Mol. Biol. 318:1–8.
18. Fromme, R., Z. Katiliene, B. Giomarelli, F. Bogani, J. McMahon, et al.
2007. A monovalent mutant of cyanovirin-N provides insight into the
role of multiple interactions with gp120 for antiviral activity. Biochem-
istry. 46:9199–9207.
19. Barrientos, L. G., F. Lasala, R. Delgado, A. Sanchez, and A. M.
Gronenborn. 2004. Flipping the switch from monomeric to dimeric
CV-N has little effect on antiviral activity. Structure. 12:1799–1807.
20. Mori, T., L. G. Barrientos, Z. Han, A. M. Gronenborn, J. A. Turpin, et al.
2002. Functional homologs of cyanovirin-N amenable to mass produc-
tion in prokaryotic and eukaryotic hosts. Protein Expr. Purif. 26:42–49.
21. Liu, Y., J. R. Carroll, L. A. Holt, J. McMahon, B. Giomarelli, et al.
2009. Multivalent interactions with gp120 are required for the anti-
HIV activity of cyanovirin. Biopolymers. 92:194–200.
22. Fromme, R., Z. Katiliene, P. Fromme, and G. Ghirlanda. 2008. Confor-
mational gating of dimannose binding to the antiviral protein cyanovirin
revealed from the crystal structure at 1.35 A resolution. Protein Sci.
17:939–944.
23. Anselmi, M., M. Brunori, B. Vallone, and A. Di Nola. 2008. Molecular
dynamics simulation of the neuroglobin crystal: comparison with the
simulation in solution. Biophys. J. 95:4157–4162.
24. Neugebauer, A., C. D. Klein, and R. W. Hartmann. 2004. Protein-
dynamics of the putative HCV receptor CD81 large extracellular
loop. Bioorg. Med. Chem. Lett. 14:1765–1769.
25. Cerutti, D. S., I. Le Trong, R. E. Stenkamp, and T. P. Lybrand. 2008.
Simulations of a protein crystal: explicit treatment of crystallization
conditions links theory and experiment in the streptavidin-biotin
complex. Biochemistry. 47:12065–12077.
26. Malek, K., and M. O. Coppens. 2008. Molecular simulations of solute
transport in xylose isomerase crystals. J. Phys. Chem. B. 112:1549–
1554.Biophysical Journal 97(9) 2532–2540
2540 Vorontsov and Miyashita27. Hu, Z., and J. Jiang. 2008. Molecular dynamics simulations for water
and ions in protein crystals. Langmuir. 24:4215–4223.
28. Bond, P. J., J. D. Faraldo-Gomez, S. S. Deol, and M. S. Sansom. 2006.
Membrane protein dynamics and detergent interactions within a crystal: a
simulation study of OmpA. Proc. Natl. Acad. Sci. USA. 103:9518–
9523.
29. Meinhold, L., and J. C. Smith. 2005. Fluctuations and correlations in
crystalline protein dynamics: a simulation analysis of staphylococcal
nuclease. Biophys J. 88:2554–2563.
30. Krieger, E., T. Darden, S. B. Nabuurs, A. Finkelstein, and G. Vriend.
2004. Making optimal use of empirical energy functions: Force-field
parameterization in crystal space. Proteins. 57:678–683.
31. Baucom, J., T. Transue, M. Fuentes-Cabrera, J. M. Krahn, T. A. Darden,
et al. 2004. Molecular dynamics simulations of the d(CCAACGTTGG)2
decamer in crystal environment: comparison of atomic point-charge,
extra-point, and polarizable force fields. J. Chem. Phys. 121:6998–7008.
32. Babin, V., J. Baucom, T. A. Darden, and C. Sagui. 2006. Molecular
dynamics simulations of DNA with polarizable force fields: conver-
gence of an ideal B-DNA structure to the crystallographic structure. J.
Phys. Chem. B. 110:11571–11581.
33. Shao, J., S. W. Tanner, N. Thompson, and T. E. Cheatham. 2007. Clus-
tering molecular dynamics trajectories: 1. characterizing the perfor-
mance of different clustering algorithms. J. Chem. Theory Comput.
3:2312–2334.
34. Rao, F., and A. Caflisch. 2004. The protein folding network. J. Mol.
Biol. 342:299–306.
35. Case, D. A., T. E. Cheatham, 3rd, T. Darden, H. Gohlke, R. Luo, et al.
2005. The AMBER biomolecular simulation programs. J. Comput.
Chem. 26:1668–1688.
36. Case, D. A., T. A. Darden, T. E. Cheatham, 3rd, C. L. Simmerling,
J. Wang, et al. 2008. AMBER 10. University of California, San Francisco.
37. Case, D.A., editor. 2008. AmberTools Users’ Manual.
38. Duan, Y., C. Wu, S. Chowdhury, M. C. Lee, G. Xiong, et al. 2003.
A point-charge force field for molecular mechanics simulations of
proteins based on condensed-phase quantum mechanical calculations.
J. Comput. Chem. 24:1999–2012.Biophysical Journal 97(9) 2532–254039. Kirschner, K. N., A. B. Yongye, S. M. Tschampel, J. Gonzalez-Outeirino,
C. R. Daniels, et al. 2008. GLYCAM06: a generalizable biomolecular
force field. Carbohydrates. J. Comput. Chem. 29:622–655.
40. Ponder, J. W., and D. A. Case. 2003. Force fields for protein simula-
tions. Adv. Protein Chem. 66:27–85.
41. DeMarco, M. L., and R. J. Woods. 2004. 2008. Structural glycobiology:
a game of snakes and ladders. Glycobiology. 18:426–440.
42. Cerutti, D. S., R. Duke, P. L. Freddolino, H. Fan, and T. P. Lybrand.
2008. Vulnerability in popular molecular dynamics packages concern-
ing Langevin and Andersen dynamics. J. Chem. Theory Comput.
4:1669–1680.
43. Humphrey, W., A. Dalke, and K. Schulten. 1996. VMD: visual molec-
ular dynamics. J. Mol. Graph. 14:33–38.
44. DeLano, W. L. 2008. The PyMOL Molecular Graphics System.
DeLano Scientific, Palo Alto, CA, USA.
45. Wallace, A. C., R. A. Laskowski, and J. M. Thornton. 1995. LIGPLOT:
a program to generate schematic diagrams of protein-ligand interac-
tions. Protein Eng. 8:127–134.
46. Shannon, P., A. Markiel, O. Ozier, N. S. Baliga, J. T. Wang, et al. 2003.
Cytoscape: a software environment for integrated models of biomolec-
ular interaction networks. Genome Res. 13:2498–2504.
47. Lovell, S. C., J. M. Word, J. S. Richardson, and D. C. Richardson. 2000.
The penultimate rotamer library. Proteins. 40:389–408.
48. Vorontsov, I. I., and P. Coppens. 2005. On the refinement of time-
resolved diffraction data: comparison of the random-distribution and
cluster-formation models and analysis of the light-induced increase in
the atomic displacement parameters. J. Synchrotron. Radiat. 12:488–
493.
49. Percudani, R., B. Montanini, and S. Ottonello. 2005. The anti-HIV
cyanovirin-N domain is evolutionarily conserved and occurs as a protein
module in eukaryotes. Proteins. 60:670–678.
50. Koharudin, L. M., A. R. Viscomi, J. G. Jee, S. Ottonello, and A. M.
Gronenborn. 2008. The evolutionarily conserved family of cyano-
virin-N homologs: structures and carbohydrate specificity. Structure.
16:570–584.
